Author:
Cankovic Milena,Mikkelsen Tom,Rosenblum Mark L,Zarbo Richard J
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology,Pathology and Forensic Medicine
Reference27 articles.
1. Hulleman E, Helin K . Molecular mechanisms in gliomagenesis. Adv Cancer Res 2005;94:1–21.
2. Andesson U, Malmer B, Bergenheim AT, et al. Heterogeneity in the expression markers of drug resistance in brain tumors. Clin Neuropathol 2004;23:21–27.
3. Nieder C, Adam M, Grosu AL . Combined modality treatment of glioblastoma multiforme: the role of Temozolomide. Rev Recent Clin Trials 2006;1:43–51.
4. Hegi ME, Diserens A-C, Gorlia T, et al. MGMT gene silencing and benefit from Temozolomide in glioblastomas. N Engl J Med 2005;352:997–1003.
5. Stupp R, Dietrich P-Y, Kraljevic SO . Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus Temozolomide followed by adjuvant Temozolomide. J Clin Oncol 2002;20:1375–1382.
Cited by
59 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献